Navigation Links
Zebrafish discovery may shed light on human kidney function
Date:2/20/2014

ROCHESTER, Minn. Feb. 20, 2014 Researchers say the discovery of how sodium ions pass through the gill of a zebrafish may be a clue to understanding a key function in the human kidney. The findings from a collaboration between Mayo Clinic and the Tokyo Institute of Technology appear in the online issue of the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.

The researchers discovered a protein responsible for gas exchanges in the fish gill structure. Specifically they studied and characterized the Na+/H+ (sodium/hydrogen) exchanger named NHE3, responsible for controlling sodium and hydrogen ions across the gill. The researchers also directly demonstrated that NHE3 can function as a Na+/NH4+ (sodium/ammonium) exchanger.

"This is significant because the fish tends to mimic the process in humans," says Michael Romero, Ph.D., a Mayo Clinic physiologist who works in nephrology. "This is the true beauty of comparative physiology- a lot of the organs function by very similar processes, down to ionic transfer."

In this case the protein allows the sodium ions to be absorbed from the forming urine while at the same time discarding waste from normally functioning cells, thus keeping the body in balance and serving as an energy saving system. The researchers say the same NHE3 protein performs a similar function in the intestine, pancreas, liver, lungs and reproductive system.

The gill is used in the fish as a transport system: sodium ions are nutrients and ammonium carries away waste. It's a key process allowing zebrafish to extract sodium ions from fresh water. In humans, NHE3 is involved in the acid-waste control system in the kidney, but there hasn't been a good analysis of that process in humans. Part of this acid-control process in the human kidney is "ammoniagenesis" which requires the initial part of the kidney tubule (proximal tubule) to export ammonia/ammonium. Physiologically, it has been assumed that NHE3 can perform a Na+/NH4+ exchange, but this has never been experimentally demonstrated.

Ammoniagenesis and increased renal sodium bicarbonate absorption are partly under the control of the renin-angiotensin-aldosterone system (RAAS), which means that this work enhances understanding of human hypertension. Researchers say their results in fish can be a clue or starting point for analyzing the process in people. Researchers say they hope to continue their work in other species and ultimately further describe the process in humans.


'/>"/>

Contact: Bob Nellis
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. For first time, drug developed based on zebrafish studies passes Phase I clinical trial
2. Family ties: Relationship between human and zebrafish genomes
3. The zebrafish revealed a central regulator for the development of the brain histamine system
4. Individual gene differences can be tested in zebrafish
5. Tension on gut muscles induces cell invasion in zebrafish intestine, mimicking cancer metastasis
6. Zebrafish reveal promising mechanism for healing spinal cord injury
7. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
8. NUS researchers make new discovery of protein as a promising target for treatment of ATC
9. Drug discovery potential of natural microbial genomes
10. Prion discovery could help keep deadly brain diseases in check
11. Autism Learning Games: Camp Discovery App Utilizes Technology to Revolutionize Learning for Children with Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: